We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Rutgers

News List

Evelo, Rutgers, RWJ Submit IND for Study of EDP1815 as COVID-19 Treatment americanpharmaceuticalreview
May 11, 2020
Evelo Biosciences, Rutgers University, and Robert Wood Johnson University Hospital (RWJ) announced the submission of an Investigational New Drug (IND) application.
Santhera, Rutgers Sign Gene Therapy Research Agreements americanpharmaceuticalreview
May 08, 2020
Santhera Pharmaceuticals announces the signing of two agreements with Rutgers, The State University of New Jersey as part of its program to advance gene therapy research for the treatment of LAMA2-deficient congenital muscular dystrophy.
Rutgers Coronavirus Saliva Test Receives FDA Approval americanpharmaceuticalreview
April 21, 2020
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavir
Doctors turning to antibiotic alternatives to treat acne sciencedaily
May 14, 2019
Physicians are scaling back on prescribing antibiotics for long-term acne treatment in favor of a combinations of therapies, according to Rutgers researchers.